Specifically, elevated levels of the pro-inflammatory cytokine IL-1β have been observed in Alzheimer’s disease lesions in human post-mortem tissue, and IL-1β knockout mice exhibit resistance to LPS-induced Parkinson’s-like symptoms3, 23. This evidence concerns the gene IL1B and early-onset autosomal dominant Alzheimer disease.